The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2,6-diethylphenyl)-N-isopropyl-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxamide ID: ALA4874264
PubChem CID: 137548857
Max Phase: Preclinical
Molecular Formula: C29H30ClN3O2S
Molecular Weight: 520.10
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cccc(CC)c1-n1c(C)c(C(=O)NC(C)C)cc(-c2nc(-c3ccc(Cl)cc3)cs2)c1=O
Standard InChI: InChI=1S/C29H30ClN3O2S/c1-6-19-9-8-10-20(7-2)26(19)33-18(5)23(27(34)31-17(3)4)15-24(29(33)35)28-32-25(16-36-28)21-11-13-22(30)14-12-21/h8-17H,6-7H2,1-5H3,(H,31,34)
Standard InChI Key: FYVUXNWOWDKKCJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
17.8748 -4.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8748 -5.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5868 -5.8957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2989 -5.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2989 -4.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5868 -4.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0127 -5.9010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1609 -5.9010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1591 -4.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1567 -3.4271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4459 -4.6666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5864 -6.7199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8703 -7.1318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8700 -7.9560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5849 -8.3693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3018 -7.9524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2986 -7.1296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0132 -4.2490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7658 -4.5867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3197 -3.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9093 -3.2595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1019 -3.4288 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.1356 -4.0642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4681 -4.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2876 -4.9093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7753 -4.2428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4378 -3.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6194 -3.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5956 -4.3303 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.0119 -6.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7275 -7.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1562 -6.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4413 -7.1303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7302 -4.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7278 -3.4312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0170 -4.6709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
2 8 1 0
1 9 1 0
9 10 2 0
9 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
3 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
5 18 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
26 29 1 0
17 30 1 0
30 31 1 0
13 32 1 0
32 33 1 0
11 34 1 0
34 35 1 0
34 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 520.10Molecular Weight (Monoisotopic): 519.1747AlogP: 6.85#Rotatable Bonds: 7Polar Surface Area: 63.99Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 6.98CX LogD: 6.98Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: -1.40
References 1. Rohde JM, Karavadhi S, Pragani R, Liu L, Fang Y, Zhang W, McIver A, Zheng H, Liu Q, Davis MI, Urban DJ, Lee TD, Cheff DM, Hollingshead M, Henderson MJ, Martinez NJ, Brimacombe KR, Yasgar A, Zhao W, Klumpp-Thomas C, Michael S, Covey J, Moore WJ, Stott GM, Li Z, Simeonov A, Jadhav A, Frye S, Hall MD, Shen M, Wang X, Patnaik S, Boxer MB.. (2021) Discovery and Optimization of 2H -1λ2 -Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer., 64 (8.0): [PMID:33822623 ] [10.1021/acs.jmedchem.1c00019 ]